Edition:
United States

People: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.15USD
22 Jul 2016
Change (% chg)

-- (--)
Prev Close
$2.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
156,478
52-wk High
$2.89
52-wk Low
$0.94

Harrington, John 

Dr. John J. Harrington, Ph.D., is Executive Vice President, Chief Scientific Officer, Director of Athersys Inc. Dr. Harrington led the development of the RAGE® technology, as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on over 20 issued or pending United States patents, has authored numerous scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception, and is also focused on the clinical development and manufacturing of MultiStem®. During his career, he has also held positions at Amgen and Scripps Clinic. He earned his B.A. in Biochemistry and Cell Biology from the University of California at San Diego and his Ph.D. in Cancer Biology from Stanford University.

Basic Compensation

Total Annual Compensation, USD 462,015
Restricted Stock Awards, USD 88,862
Long-Term Incentive Plans, USD --
All Other, USD 177,713
Fiscal Year Total, USD 728,590

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gil Bokkelen

1,061,010

William Lehmann

731,730

John Harrington

728,590

Robert Deans

611,453

Laura Campbell

515,837

Lee Babiss

--
As Of  30 Dec 2014